This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Curley, F. J. Articles by Irwin, R. S. Search for Related Content PubMed Articles by Curley, F. J. Articles by Irwin, R. S. Social Bookmarking                         What's this?

Disorders of Temperature Control: Hyperthermia, Part II

Pulmonary Medicine Division, University of Massachusetts Medical School, Worcester, MA

Richard S. Irwin, MD

Pulmonary Medicine Division, University of Massachusetts Medical School, Worcester, MA

Malignant hyperthermia and neuroleptic malignant syndrome, two hyperthermic syndromes, are discussed with respect to their pathogenesis, pathophysiological factors, diagnosis, differential diagnosis, and treatment. Malignant hyperthermia is a drug- or stress-induced hypermetabolic syndrome characterized by vigorous muscular contractures and cardiovascular collapse. Neuroleptic malignant syndrome results primarily from an imbalance of central neurotransmitters caused by neuroleptic drug use and characterized by mental status changes and muscular rigidity. Recognition and prompt treatment of these disorders reduces their morbidity and mortality.

Journal of Intensive Care Medicine, Vol. 1, No. 2, 91-100 (1986)
DOI: 10.1177/088506668600100205


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?